MA

Mahesh Ashokrao Patil

Active Director Director DIN 10723319
DIN 10723319 First appointment Jul 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahesh Ashokrao Patil

Data last updated:

Mahesh Ashokrao Patil is a Director at Healnest Research India Private Limited (since 2024) and Director at Rootrakshan Health Care Private Limited (since 2024).

DIN 10723319
Primary Designation Director
First Appointment 29 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Dec 20242024Active
Director29 Jul 20242024Active

Directorship timeline

Open interactive timeline →
Healnest Research India Private Limited
Rootrakshan Health Care Private Limited
Premium access

Shareholding and investment profile for Mahesh Ashokrao Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Ashokrao Patil

Mahesh Ashokrao Patil currently holds 2 directorships: Healnest Research India Private Limited (Director, since 18 Dec 2024); Rootrakshan Health Care Private Limited (Director, since 29 Jul 2024).

Mahesh Ashokrao Patil was first appointed on 29 Jul 2024 as Director at Rootrakshan Health Care Private Limited.

The current boards of Mahesh Ashokrao Patil's companies include Nitin Narayan Jadhav (Healnest Research India Private Limited), Suhas Shankar Panchal (Rootrakshan Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available